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The 37-kDa/67-kDa laminin receptor (LRP/LR), also known as ribosomal protein SA (RPSA), acts as a 
cell surface receptor for prions and plays an important role in internalization of cellular prion protein. In 
this study, we knocked out the part of prion binding sites (aa 161-205) by gene targeting in the bovine 
fetal fibroblasts (BFF). This is the first report about disrupting the gene encoding for the prion binding 
site in bovine fetal fibroblasts. The heterozygous BFF are ready to be used in producing homozygous 
cattle, which will be applied to study the interaction between prion and the 37-kDa/67-kDa LRP/LR. 
 









Prion diseases are a group of fatal, infectious, neuro-
degenerative disorders, including Creutzfeldt-Jakob 
disease (CJD) in humans, scrapie in sheep, bovine 
spongiform encephalopathy (BSE) in cattle and wasting 
disease in deer (CWD) (Collinge, 2001). The principal 
hallmarks of these diseases are brain vacuolation, 
neuronal apoptosis and astrogliosis (Yu et al., 2006). 
Compelling evidences show that the infectious agent is 
prion, which is composed by a misfolded form of the prion 
protein (PrP
Sc
) that propagates in the absence of nucleic 
acid (Prusiner, 1998). PrP
C
 is secreted in the cell surface 
and anchored there by glycosylphosphatidyl inositol (GPI) 
(Stahl et al., 1992). Studies show that PrP
C
 binds to its 
cell surface receptor, the 37-kDa/67-kDa laminin receptor 
(LRP/LR, “LRP” denotes the 37-kDa laminin receptor 
precursor, and “LR” denotes the 67-kDa high-affinity 
laminin receptor), which is important for the inter-
nalization of PrP
C
 (Gauczynski et al., 2001).  
The 37-kDa/67-kDa laminin receptor (LRP/LR), also 
called as ribosomal protein SA (RPSA) is a non-integrin 
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37-kDa LRP and 67-kDa LR can be explained that the 
mature 67-kDa LR is composed  of  37-kDa LRP  coupled 
with an unidentified factor (Castronovo et al., 1991; Butò 
et al., 1998). The function of 37-kDa/67-kDa LRP/LR is 
involved in many aspects. There is a relationship 
between 67-kDa LR and tumor invasion, expression of 
67-kDa LR has been increased in various cancers (Zuber 
et al., 2008b; Mbazima et al., 2010; Omar et al., 2011); in 
addition, LRP/LR has been identified as a binding partner 
for cellular PrP (Rieger et al., 1997), as a receptor for 
PrP
C
 internalization (Gauczynski et al., 2001), and as a 
receptor for PrP
Sc
 (Prions) (Gauczynski et al., 2006) 
playing an important role for PrP
Sc
 propagation in vitro 
(Leucht et al., 2003).  
The bovine 37-kDa/67-kDa LRP/LR gene is located on 
chromosome 22, and encodes a protein of 295 amino 
acids, there are two prion binding sites, direct binding site 
[amino acids (aa) 161-179] and another is indirect 
interaction site [amino acids (aa) 180-285]. The latter 
depends on the heparan sulfate proteoglycan (Hundt et 
al., 2001). The two binding sites can be blocked to bind 
with prion by antibodies specific for the 37-kDa/67-kDa 
LRP/LR, and antisense RNA and siRNA can also reduce 
the expression of the receptor (Leucht et al., 2003). The 
direct and part of the indirect (aa 180-205) prion binding 
sites are located in two adjacent exons. Therefore, in this 
study we sought to disrupt the two sites by gene targeting  






Figure 1. Diagram of the targeting PNS-GLR vector. The PNS-GLR vector was about 12 kb, XhoI and NotI 
were restriction-enzyme sites between pORF-HSVtk and L-neo, L-neo and right arm, right arm and pORF-
HSVtk. A, B, C, represented three products of PCR amplification, which were 1258, 1235 and 1564 bp, 






Figure 2. Restriction-enzyme digestion analysis 
of the PNS-GLR vector. Lane M1: 1kb DNA 
marker; lane M2: Trans 2k plus DNA marker; 
lane 1: digestion with XhoI and NotI; lane 2: 
digestion with NotI; lane 3: digestion with XhoI. 
The positions of the restriction-enzyme sites 




in the bovine fetal fibroblasts (BFF) by using the vector of 
positive-negative selection. The results  showed  that  the 
37-kDa/67-kDa LRP/LR gene was successfully disrupted. 
 
 
MATERIALS AND METHODS 
 
Construction of positive-negative selection targeting vector 
 
Several studies were performed to confirm that the fragments were 
ligated correctly or not when  L-neo  fragment  and  right  arm  were 
inserted   into   the    gene    targeting     vector   pORF-HSVtk.  The  
restriction-enzyme sites of the PNS-GLR vector are shown in Figure 
1a. The total length of the PNS-GLR vector was 11996 bp; the 
fragment should be about 12 kb (pORF-HSVtk vector) when 
digested by Xho I. Two bands were obtained when digested by Not 
I, one was about 5.0 kb (right arm) and another was 7.0 kb (L-neo 
fragment and pORF-HSVtk vector). The L-neo arm (2.6 kb) and 
right arm (5.0 kb) and pORF-HSVtk vector (4.4 kb) were obtained 
(Figure 2) when the PNS-GLR vector was digested by Xho I and 
Not I. In addition, we designed three pairs primers across the L-neo 







Figure 3. Diagram of the gene targeting LRP/LR locus. P1/P3, P2/P4, P5/P6 represent the three pairs of PCR 






Figure 4. PCR analysis of G418-resistant and GANC-resistant colonies. Colonies are indicated above 
each lane. Lane M: Trans 2k plus DNA marker. The locations of the PCR primers are shown in Figure 1. 




products were 1258 bp (A), 1235 bp (B) and 1564 bp (C), 
respectively (Figure 1b). Restriction-enzyme digestion and gene 




Transfection and selection of the bovine fetal fibroblasts 
 
The bovine fetal fibroblasts cell lines were from 35-day fetuses of 
Herstan cow. The PNS-GLR vector was linearized by Xho I and 
transfected into bovine fetal fibroblasts by an electroporation 
apparatus. When homologous recombination occurred between the 
endogenous LRP/LR and the PNS-GLR vector, the targeted cells 
can survive from G418 and GANC selection. In order to examine 
whether the homologous recombination occurred between PNS-
GLR vector and endogenous LRP/LR locus, we designed three 
pairs of primers, P1/P3, P2/P4 and P5/P6 (Figure 3). The results of 
gene sequencing confirmed that the homologous recombination 
occurred correctly (Figure 4). 
Detection of 37-kDa/67-kDa LRP/LR mRNA expression levels in 
targeted cells  
 
To examine the 37-kDa/67-kDa LRP/LR mRNA expression levels in 
targeted cells, the reverse transcription PCR and real-time 
quantitative PCR analysis were performed, and the results are 
shown in Figure 5a and b, respectively. The levels of 37-kDa /67-
kDa LRP/LR gene expression in targeted cells (colony 1 and colony 
2) were significantly lower than that of in the control cells; all 
samples were tested in triplicate. Differences in mRNA expression 
levels between targeted and control groups were statistically 
significant (p < 0.05, Figure 5b), which indicated that the 37-kDa/67-




RESULTS AND DISCUSSION 
 
In the process of the  prion  disease,  the  37-kDa/67-kDa  






Figure 5. RT-PCR and real-time quantitative PCR analysis of expression levels 
of 37-kDa/67-kDa LRP/LR in control and targeted cells (1). (a) 1% agarose gel 
electrophoresis of RT-PCR products of LRP/LR gene. As a control, RT-PCR 
products were standardized by analysis of constitutive expression of β-actin 
gene. (b) Relative LRP/LR mRNA expression, all values were normalized to β-
actin mRNA expression levels and are expressed as means ± SD (n = 3). A 




LRP/LR plays an important role in internalization of PrP
C
 
and propagation of PrP
Sc
. The 37-kDa/67-kDa LRP/LR is 
a multifunctional protein and is expressed within the 
cytoplasm, the nucleus and the plasma membrane, 
respectively (Vana et al., 2007, 2009; Mbazima et al., 
2010; Omar et al., 2011), and the 37-kDa/67-kDa LRP/LR 
was identified as the cell surface receptor for PrP
C
 
(Gauczynski et al., 2001; Hundt et al., 2001) and for 
infectious prions (Gauczynski et al., 2006), bovine prions 
are endocytosed in an LRP/LR-dependent manner by 
human enterocytes (Morel et al., 2005; Kolodziejczak et 
al., 2010 ), which confirmed the importance of the 37-
kDa/67-kDa LRP/LR in the prion infection. Therefore, 
several therapeutic approaches targeting the 37-kDa/67-
kDa LRP/LR have been developed including (a) LRP/LR 
decoy mutant (Pflanz et al., 2009b), (b) small interfering 
RNAs directed against the LRP/LR mRNA (Leucht et al., 
2003; Pflanz et al., 2009a), (c) anti-LRP/LR antibodies 
(Zuber et al., 2007, 2008a, c), and (d) polysulfated 
glycans (Gauczynski et al., 2006), and all of these 
approaches can prevent PrP
Sc
 propagation efficiently. 
With the development of cloning techniques, transgenic 
animals  can   be   generated   by   nuclear  transfer  from 
transfected fetal fibroblasts cultured in vitro (Schnieke et 
al., 1997) and the procedures are essentially the same as 
those required for gene targeting (Capecchi, 1989; Wang 
et al., 2003). In this study, in order to further understand 




, we knocked out 
one allele of the direct and part of the indirect binding 
sites gene so that the bovine fetal fibroblasts with 
reduced LRP/LR expression will be useful in prion 
research. Moreover, to avoid the possible influence of 
ribosomal protein SA (RPSA) pseudogenes on the RT-
qPCR measurements, precautions were taken to rule out 
this influence such as identifying the sequence of the 
genes amplified during the experiment to make sure 
there are no pseudogenes. Additionally, it should be 
noted that up to now, no detailed analysis of the RPSA 
gene family has been performed in bovine; hence it is 
therefore difficult to know if no pseudogenes with (nearly) 
identical sequence exist. 
After gene targeting, DNA analyses indicate that one 
allele of the 37-kDa/67-kDa LRP/LR gene has been 
disrupted successfully. In addition, real-time quantitative 
PCR analyses showed that the expression level of 37-





targeted cells had the normal abilities of cell division; 
however, more details about whether the two binding 
sites are essential for normal animal development will be 
conducted in future work. We are aware of the existence 
of RPSA pseudogenes and their possible influence on the 
RT-qPCR measurements. Precautions were taken to rule 
out this influence, such as identifying the sequence of the 
genes amplified during the experiment to make sure 
there are no pseudogenes 
To date, this is the first report about disrupting the 
binding sites of the 37-kDa/67-kDa LRP/LR gene in 
bovine fetal fibroblasts. In the future, we hope to conduct 
nuclear transfer to produce heterozygous cattle. We 
expect to achieve the homozygous bovine devoid of the 
37-kDa/67-kDa LRP/LR gene after finishing the second-
round gene targeting, and eventually, we will test if bovine 
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